BIOTECHNOLOGICAL ROUTES FOR INSULIN PRODUCTION

ASANI, Lutfi and HOXHA, Vlera and XHAFERI, Shqipe and Ahmeti Lika, Sihana (2026) BIOTECHNOLOGICAL ROUTES FOR INSULIN PRODUCTION. In: INTERNATIONAL CONFERENCE “FROM RESEARCH TO APPLICATION”, 20 May, 2026.

[img] Text
Proceedings Book 2026-2 (1)-708-713.pdf
Download (428kB)

Abstract

Insulin is a peptide hormone produced by β-cells of the Islets of Langerhans in the pancreas and plays a central role in regulating blood glucose homeostasis. Historically, insulin therapy relied on extraction from animal pancreases, but this approach was limited by supply constraints, variable purity, and immunogenic reactions. The introduction of recombinant DNA technology in the late 20th century transformed insulin production by enabling biosynthesis in microorganisms such as Escherichia coli and Saccharomyces cerevisiae. These advances allowed the large-scale production of highly purified human insulin and eliminated dependence on animal sources. This study reviews the evolution of insulin production methods, from animal-derived extraction to recombinant biosynthetic approaches, including the development of proinsulin-based systems and yeast expression platforms. Furthermore, it examines the structural and functional properties of insulin, its biosynthesis, receptor interactions, and metabolic effects on carbohydrates, lipids, and proteins. Special attention is given to insulin analogues, including rapid-acting (Humalog, NovoLog, Apidra) and long-acting (Lantus, Levemir) formulations, which were developed through targeted amino acid modifications to improve pharmacokinetic profiles and therapeutic outcomes. Recombinant insulin and its analogues have significantly improved diabetes management by providing greater safety, consistency, and flexibility in treatment. Additionally, innovations such as insulin pens and advanced delivery systems have enhanced patient adherence. Overall, the development of recombinant insulin represents a major milestone in biotechnology and has fundamentally reshaped modern diabetes therapy.

Item Type: Conference or Workshop Item (Paper)
Subjects: R Medicine > R Medicine (General)
Divisions: Faculty of Medicine, Health and Life Sciences > School of Medicine
Depositing User: Unnamed user with email zshi@unite.edu.mk
Date Deposited: 22 Sep 2026 12:43
Last Modified: 22 Sep 2026 12:43
URI: http://eprints.unite.edu.mk/id/eprint/2450

Actions (login required)

View Item View Item
Universiteti i Tetoves is powered by EPrints 3 which is developed by the School of Electronics and Computer Science at the University of Southampton. More information and software credits.